[Spiroergometric evaluation of the effectiveness of treatment of cardiac insufficiency with cardiac glycosides].
There were 29 patients with rheumatic heart disease and early stages of cardiac insufficiency under observation. Spiroergometry with the "Ergotest" device was conducted in dynamics to check whether the proper dose of the cardiac glycoside had been chosen. The results attest to the considerable improvement in the spiroergometric indices in patients with early stages of cardiac insufficiency who had been treated with digitalis. Spiroergometry yielded important additional criteria of the effectiveness of digitalization, particularly in individuals with normal or diminished rate of cardiac contractions.
D000293:Adolescent; D000328:Adult; D004077:Digoxin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D012119:Respiration; D012214:Rheumatic Heart Disease / Q000188:drug therapy* / Q000503:physiopathology; D013147:Spirometry
D004077:Digoxin
Otsenka effektivnosti lecheniia serdechnymi glikozidami bol'nykh s serdechnoĭ nedostatochnost'iu s pomoshch'iu spiroergometrii.